Camp4 Therapeutics Corp

NEW
NAS:CAMP (USA)  
$ 5.29 +0.73 (+16.01%) 04:00 PM EST
At Loss
Market Cap:
$ 106.65M
Enterprise V:
$ 98.86M
Volume:
24.20K
Avg Vol (2M):
36.10K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
24.20K
At Loss
Avg Vol (2M):
36.10K

Business Description

Description
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
Name Current Vs Industry Vs History
Cash-To-Debt 0.27
Equity-to-Asset -7.44
Debt-to-Equity -0.06
Debt-to-EBITDA -0.36
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -18.96
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.92
9-Day RSI 41.07
14-Day RSI 45.1
3-1 Month Momentum % -7.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.47
Quick Ratio 0.47
Cash Ratio 0.21

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -12809.43
ROA % -74.75
ROIC % -135.02
ROC (Joel Greenblatt) % -224.93
ROCE % -102.72

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 170.4
EV-to-EBIT -3.66
EV-to-EBITDA -3.78
EV-to-Revenue 282.45
EV-to-FCF -2.4
Earnings Yield (Greenblatt) % -27.32
FCF Yield % -42.04

Financials

CAMP's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CAMP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Camp4 Therapeutics Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.35
EPS (TTM) ($) -1.762
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 45.1
14-Day ATR ($) 0.627786
20-Day SMA ($) 4.905
12-1 Month Momentum % -
52-Week Range ($) 3.5 - 12.3
Shares Outstanding (Mil) 20.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Camp4 Therapeutics Corp Filings

Filing Date Document Date Form
No Filing Data

Camp4 Therapeutics Corp Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Camp4 Therapeutics Corp Frequently Asked Questions

What is Camp4 Therapeutics Corp(CAMP)'s stock price today?
The current price of CAMP is $5.29. The 52 week high of CAMP is $12.30 and 52 week low is $3.50.
When is next earnings date of Camp4 Therapeutics Corp(CAMP)?
The next earnings date of Camp4 Therapeutics Corp(CAMP) is .
Does Camp4 Therapeutics Corp(CAMP) pay dividends? If so, how much?
Camp4 Therapeutics Corp(CAMP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1